37 C.F.R. § 2.65

Current through October 31, 2024
Section 2.65 - Abandonment
(a) An application will be abandoned if an applicant fails to respond to an Office action, or to respond completely, within the relevant time period for response under § 2.62(a)(1) , including any granted extension of time to respond under § 2.62(a)(2) . A timely petition to the Director pursuant to §§ 2.63(a) and (b) and 2.146 or notice of appeal to the Trademark Trial and Appeal Board pursuant to § 2.142 , if appropriate, is a response that avoids abandonment (see § 2.63(b)(4) ).
(1) If all refusals and/or requirements are expressly limited to certain goods and/or services, the application will be abandoned only as to those goods and/or services.
(2) When a timely response by the applicant is a bona fide attempt to advance the examination of the application and is a substantially complete response to the examining attorney's action, but consideration of some matter or compliance with a requirement has been omitted, the examining attorney may grant the applicant 30 days, or to the end of the time period for response to the action to which the substantially complete response was submitted, whichever is longer, to explain and supply the omission before the examining attorney considers the question of abandonment.
(b) An application will be abandoned if an applicant expressly abandons the application pursuant to § 2.68 .
(c) An application will be abandoned if an applicant in an application under section 1(b) of the Act fails to timely file either a statement of use under § 2.88 or a request for an extension of time for filing a statement of use under § 2.89 .

37 C.F.R. §2.65

80 FR 2311 , Jan. 16, 2015, as amended at 86 FR 64326 , Nov. 17, 2021
86 FR 64300 , 12/1/2022

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.